Next-Gen Users Move to ‘Real’ Projects At AGBT as New Systems Make Debut | GenomeWeb
Existing next-gen sequencing platforms have moved beyond the initial testing phase of applications, and are now being used for a variety of scientific projects, including genome-wide structural variation studies, transcription or methylation analyses, and targeted resequencing, according to platform users.
 
These users presented their work at last week’s Advances in Genome Biology and Technology Conference on Marco Island, Fla., where two companies also showed new sequencing technologies: Pacific Biosciences and Danaher Motion – Dover.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.